Literature DB >> 3543144

Mononuclear cell infiltrates in bullous disease.

M S Nestor, A J Cochran, A R Ahmed.   

Abstract

Mononuclear cell subset-specific monoclonal antibodies, indirect immunoperoxidase labeling, and a specific quantification technique were used to determine the constitution of mononuclear cell infiltrates associated with bullous pemphigoid (BP), pemphigus vulgaris (PV), dermatitis herpetiformis (DH), and linear IgA bullous disease, as well as those in normal skin (NS) from healthy adult volunteers. Bullous pemphigoid and PV lesions contain significantly greater numbers of T lymphocytes (p less than 0.001), including both T helper/inducer and T cytotoxic/suppressor subsets, macrophages (p less than 0.002), and Langerhans cells (p less than 0.01), than NS or lesions of DH, supporting the concept that cell-mediated immunity is involved in bulla formation and autoantigen presentation in BP and PV. The infiltrates associated with DH lesions appear to reflect a different mechanism of autoantibody production and bulla formation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3543144     DOI: 10.1111/1523-1747.ep12525315

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Langerhans' cells are depleted in chronic graft versus host disease.

Authors:  S Aractingi; E Gluckman; M C Dauge-Geffroy; C Le Goué; A Flahaut; L Dubertret; E Carosella
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

3.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

6.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

7.  Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid.

Authors:  J Schaller; T Giese; M Ladusch; U F Haustein
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

8.  Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.

Authors:  Julie Plée; Sébastien Le Jan; Jérôme Giustiniani; Coralie Barbe; Pascal Joly; Christophe Bedane; Pierre Vabres; François Truchetet; François Aubin; Frank Antonicelli; Philippe Bernard
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

9.  Thymic Stromal Lymphopoietin Is Implicated in the Pathogenesis of Bullous Pemphigoid by Dendritic Cells.

Authors:  Si-Zhe Li; Xin-Xing Jin; Xiao-Lei Ge; Ya-Gang Zuo; Hong-Zhong Jin
Journal:  J Immunol Res       Date:  2020-09-24       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.